QantX
  • Home
  • Invest
  • Team
  • Strategy
  • Portfolio
  • News
  • Contact
  • Investor Portal
Select Page
QantX Spearheads £3m Investment for Innovative Cancer Screening Technology

QantX Spearheads £3m Investment for Innovative Cancer Screening Technology

by Harry | Oct 8, 2024 | Healthcare, Portfolio

Xgenera has secured £3m in funding, with investment led by QantX alongside a substantial £2.5m grant from the National Institute for Health and Care Research (NIHR). This investment marks a pivotal advancement in cutting-edge tumour detection methods. Dr. Andy...
Kelpi lands £4.3m funding to take seaweed packaging to market

Kelpi lands £4.3m funding to take seaweed packaging to market

by Harry | Jun 14, 2024 | Uncategorized

Lutra Health raise £400,000 to transform eyecare pathways

Lutra Health raise £400,000 to transform eyecare pathways

by Harry | May 8, 2024 | Uncategorized

Exeter, UK, 06/05/2024 South West-founded Lutra Health has raised £400,000 from QantX and a syndicate of angels to support the commercial rollout of their platform as the definitive tool for community eyecare.  The concepts underpinning Lutra Health were developed by...
QantX Launches New 2024 Fund to Champion Early-Stage, IP-Rich Startups in the South West

QantX Launches New 2024 Fund to Champion Early-Stage, IP-Rich Startups in the South West

by Harry | May 2, 2024 | Innovation

Exeter, UK – 2 May 2024 – QantX, a pioneering venture capital firm specialising in early-stage investments, is proud to announce the launch of the QantX 2024 Fund. This new fund is dedicated to supporting innovative, intellectual property-rich startups in vital...
Celltris receives £800,000 investment to accelerate the development of lithium-ion cells

Celltris receives £800,000 investment to accelerate the development of lithium-ion cells

by Harry | Apr 9, 2024 | Uncategorized

Bristol, UK, 8th April 2024 Celltris, a Bristol based battery start-up, has received a substantial boost toward its mission to eliminate wasted internal space in lithium-ion cells, the rechargeable batteries used in electric vehicles. The company has announced the...
« Older Entries

Latest Posts

  • SENISCA: treating age-related diseases with ground-breaking science
  • Lutra Health: integrating community and hospital eyecare
  • QantX leads £600K investment round to speed up innovation in the quantum industry
  • Supporting the Full Innovation Stack: From Lab Discovery to Global Impact
  • QantX partners with the SETsquared Partnership universities on new £300m investment vehicle

enquiries@qantx.co.uk  

Investor Area

QantX (Reference number: 954072) is an Appointed Representative of Kin Capital Partners LLP (FRN: 656789). Kin Capital Partners LLP (trading as Kin Fund Services) is authorised and regulated by the Financial Conduct Authority.

© 2022 QantX. All rights reserved. Cookie Policy | Privacy Policy

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy